Mucormycosis during Coronavirus Disease pandemic: A diagnosis we cannot afford to miss
Mucormycosis is a very aggressive, devastating opportunistic fungal infection commonly involving nasal, maxillary,orbital, and cerebral regions. In the second wave of the coronavirus disease 2019 (COVID-19) pandemic, a high frequency of mucormycosis infections has been seen because of the triad of C...
Saved in:
Main Authors: | Kaneesh Karthik Arthanari, Sivakumar Annamalai, Arthiie Thangavelu, Chandrika Palanivelu, Gowtham Suresh, Sambavi Anbuselvan |
---|---|
Format: | article |
Language: | EN |
Published: |
Wolters Kluwer Medknow Publications
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e03bf5f88a0149ebad1efb12b2e4b53f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China
by: Junyan Qu, et al.
Published: (2021) -
Rhino-orbito-cerebral Mucormycosis: Pictorial Review
by: Vivek Pai, et al.
Published: (2021) -
Mucormycosis in Hematologic Malignancies: Clinical Follow-Up and Treatment Results
by: Nagehan Didem Sarı, et al.
Published: (2021) -
Inhibition of EGFR Signaling Protects from Mucormycosis
by: Tonya N. Watkins, et al.
Published: (2018) -
From the editorial desk
by: Gobichettipalayam Jegatheeswaran Anbuselvan, et al.
Published: (2021)